First human doses given in early drug safety trial
Knowledge-focused
Recruiting now
This is the first study in humans for a new drug called DF5112. Its main purpose is to check if the drug is safe and how the body handles it. The study will enroll 64 healthy adults who will receive either the drug or a placebo. Researchers will monitor participants closely for s…
Phase: PHASE1 • Sponsor: Dragonfly Therapeutics • Aim: Knowledge-focused
Last updated Mar 31, 2026 12:10 UTC